S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
OTCMKTS:TRGM

Targeted Medical Pharma Stock Forecast, Price & News

$0.02
0.00 (0.00 %)
(As of 10/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.03
52-Week Range
$0.01
$0.10
Volume
N/A
Average Volume
26,154 shs
Market Capitalization
$515,725.00
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.89
30 days | 90 days | 365 days | Advanced Chart
Receive TRGM News and Ratings via Email

Sign-up to receive the latest news and ratings for Targeted Medical Pharma and its competitors with MarketBeat's FREE daily newsletter.


Targeted Medical Pharma logo

About Targeted Medical Pharma

Targeted Medical Pharma, Inc. is a medical nutrition company, which engages in the research, development, and commercialization of amino acid based medications. It operates through the following segments: Targeted Medical Pharma (TMP), Complete Claims Processing, Inc. (CCPI), and Amino Nutritionals. The TMP segment offers medical foods and generic pharmaceuticals as PTL. The CCPI segment includes point-of-care dispensing solutions; and billing, and collection services. The Amino Nutritionals segment produces and distributes amino acid based dietary supplements directly to consumers. Its products includes Theramine, AppTrim, and Hypertensa. The company was founded by Elizabeth Charuvastra, William E. Shell, and Kim Giffoni in 1999 and is headquartered in Los Angeles, CA.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:TRGM
CUSIP
876140104
Employees
30
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$515,725.00
Next Earnings Date
N/A
Fiscal Year End
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.21 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Targeted Medical Pharma (OTCMKTS:TRGM) Frequently Asked Questions

What stocks does MarketBeat like better than Targeted Medical Pharma?

Wall Street analysts have given Targeted Medical Pharma a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Targeted Medical Pharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Targeted Medical Pharma's stock price been impacted by COVID-19 (Coronavirus)?

Targeted Medical Pharma's stock was trading at $0.0094 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TRGM stock has increased by 86.2% and is now trading at $0.0175.
View which stocks have been most impacted by COVID-19
.

Who are Targeted Medical Pharma's key executives?

Targeted Medical Pharma's management team includes the following people:
  • Marcus Charuvastra, Chief Executive Officer & Director
  • Douglas P. Gintz, Chief Marketing & Technology Officer

What other stocks do shareholders of Targeted Medical Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Targeted Medical Pharma investors own include Chesapeake Energy (CHKAQ), Biocept (BIOC), ArQule (ARQL), Arena Pharmaceuticals (ARNA), ARI Network Services (ARIS), Aoxing Pharmaceutical (AOXG), Aeolus Pharmaceuticals (AOLS), Amarin (AMRN), American International Group (AIG) and ADK (ADK).

What is Targeted Medical Pharma's stock symbol?

Targeted Medical Pharma trades on the OTCMKTS under the ticker symbol "TRGM."

How do I buy shares of Targeted Medical Pharma?

Shares of TRGM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Targeted Medical Pharma's stock price today?

One share of TRGM stock can currently be purchased for approximately $0.02.

How much money does Targeted Medical Pharma make?

Targeted Medical Pharma has a market capitalization of $515,725.00.

How many employees does Targeted Medical Pharma have?

Targeted Medical Pharma employs 30 workers across the globe.

What is Targeted Medical Pharma's official website?

The official website for Targeted Medical Pharma is www.targetedmedicalpharma.com.

Where are Targeted Medical Pharma's headquarters?

Targeted Medical Pharma is headquartered at 2980 BEVERLY GLEN CIRCLE SUITE 301, LOS ANGELES CA, 90077.

How can I contact Targeted Medical Pharma?

Targeted Medical Pharma's mailing address is 2980 BEVERLY GLEN CIRCLE SUITE 301, LOS ANGELES CA, 90077. The specialty pharmaceutical company can be reached via phone at (310) 474-9809 or via email at [email protected].


This page was last updated on 10/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.